BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$414M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$371M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$342M |
| 4 |
Microsoft
MSFT
|
+$339M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Salesforce
CRM
|
+$688M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$338M |
| 4 |
Eli Lilly
LLY
|
+$239M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.68% |
| 2 | Consumer Discretionary | 5.92% |
| 3 | Healthcare | 5.84% |
| 4 | Financials | 5.12% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TAST
3526
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $10.8K | ﹤0.01% |
2,236
-8,512
| -79% | -$32.1K |
|
|
BCOV
3527
DELISTED
Brightcove, Inc.
BCOV
| $10.8K | ﹤0.01% |
1,371
-10,704
| -89% | -$86.2K |
|
|
CETV
3528
DELISTED
Central European Media Enterprises Ltd
CETV
| $10.8K | ﹤0.01% |
3,047
-24,249
| -89% | -$89.7K |
|
3529
Independent Bank Corp
IBCP
$854M
| $10.8K | ﹤0.01% |
725
-6,057
| -89% | -$83.6K |
|
3530
Rigel Pharmaceuticals
RIGL
$782M
| $10.8K | ﹤0.01% |
588
-4,584
| -89% | -$82.5K |
|
3531
Verastem
VSTM
$604M
| $10.7K | ﹤0.01% |
520
+494
| +1,900% | +$13.1K |
|
|
JCAP
3532
DELISTED
Jernigan Capital, Inc.
JCAP
| $10.7K | ﹤0.01% |
784
-5,934
| -88% | -$76.3K |
|
|
AKRO
3533
DELISTED
Akero Therapeutics
AKRO
| $10.7K | ﹤0.01% |
430
-2,045
| -83% | -$46.7K |
|
3534
ProShares UltraShort Consumer Staples
SZK
$8.87M
| $10.7K | ﹤0.01% |
+150
| New | +$12.4K |
|
|
WMC
3535
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $10.7K | ﹤0.01% |
389
-1,364
| -78% | -$34.9K |
|
|
CASI
3536
DELISTED
CASI Pharmaceuticals
CASI
| $10.6K | ﹤0.01% |
425
-1,122
| -73% | -$24.4K |
|
3537
Omega Flex
OFLX
$304M
| $10.6K | ﹤0.01% |
100
-796
| -89% | -$75.7K |
|
|
UBX
3538
DELISTED
Unity Biotechnology
UBX
| $10.5K | ﹤0.01% |
121
-766
| -86% | -$56.8K |
|
|
ANH
3539
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $10.5K | ﹤0.01% |
6,158
-27,332
| -82% | -$42.4K |
|
|
EXPR
3540
DELISTED
Express, Inc.
EXPR
| $10.4K | ﹤0.01% |
338
-1,006
| -75% | -$37.1K |
|
|
BFX
3541
DELISTED
BowFlex Inc.
BFX
| $10.4K | ﹤0.01% |
1,121
+956
| +579% | +$5.8K |
|
3542
Evolus
EOLS
$536M
| $10.4K | ﹤0.01% |
1,960
-4,816
| -71% | -$22.2K |
|
3543
UNIFI
UFI
$127M
| $10.3K | ﹤0.01% |
803
-4,981
| -86% | -$59K |
|
|
NBEV
3544
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $10.3K | ﹤0.01% |
6,739
-16,235
| -71% | -$24.2K |
|
3545
FRP Holdings
FRPH
$425M
| $10.3K | ﹤0.01% |
508
-3,842
| -88% | -$79.5K |
|
3546
Sterling Infrastructure
STRL
$16.8B
| $10.3K | ﹤0.01% |
984
-7,027
| -88% | -$64.9K |
|
3547
Lindblad Expeditions
LIND
$2.24B
| $10.3K | ﹤0.01% |
1,334
-5,762
| -81% | -$39.8K |
|
|
PFNX
3548
DELISTED
Pfenex Inc.
PFNX
| $10.3K | ﹤0.01% |
1,233
-8,059
| -87% | -$60.3K |
|
|
HTB
3549
HomeTrust Bancshares
HTB
$831M
| $10.3K | ﹤0.01% |
642
-4,165
| -87% | -$62.6K |
|
3550
Personalis
PSNL
$1.54B
| $10.3K | ﹤0.01% |
791
-4,720
| -86% | -$52.4K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2020 Portfolio in Review
As of Q2 2020, BNP Paribas Financial Markets held 4,480 positions worth $56.7B, up 16% from $48.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $2.34B in Q2 2020, closing 174 positions and reducing 2,678 holdings. Its most notable exit was Allergan plc, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $35.2M.
- BNP Paribas Financial Markets's largest Q2 2020 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 962,483 shares worth $35.2M.
- BNP Paribas Financial Markets added most to Apple in Q2 2020, an estimated $414M increase.
- BNP Paribas Financial Markets's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2020, selling an estimated $225M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $56.7B portfolio in Q2 2020.
- BNP Paribas Financial Markets opened 164 new positions and closed 174 in Q2 2020.
- BNP Paribas Financial Markets's portfolio value rose 16% quarter-over-quarter to $56.7B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.